| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 7630757 | Journal of Pharmaceutical and Biomedical Analysis | 2014 | 12 Pages |
Abstract
- First report of metabolic differences COPD vs. different stages of lung cancer (LC).
- Human serum NMR analysis.
- NMR metabolic fingerprints were modelled using OPLS-DA.
- Discriminant models allow to distinguish COPD vs. early and advanced LC patients.
- Metabolite biomarkers may prove to be useful in distinguishing lung cancer states.
Related Topics
Physical Sciences and Engineering
Chemistry
Analytical Chemistry
Authors
Stanislaw Deja, Irena Porebska, Aneta Kowal, Adam Zabek, Wojciech Barg, Konrad Pawelczyk, Ivana Stanimirova, Michal Daszykowski, Anna Korzeniewska, Renata Jankowska, Piotr Mlynarz,